Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Analysis of Long-term Outcomes of Radiotherapy and Verteporfin Photodynamic Therapy for Circumscribed Choroidal Hemangioma.

Papastefanou VP, Plowman PN, Reich E, Pavlidou E, Restori M, Hungerford JL, Arora AK, Cohen VML, Sagoo MS.

Ophthalmol Retina. 2018 Aug;2(8):842-857. doi: 10.1016/j.oret.2017.12.002. Epub 2018 Jan 12.

PMID:
31047538
2.

Dexmedetomidine for Sedation During Noninvasive Ventilation in Pediatric Patients.

Venkatraman R, Hungerford JL, Hall MW, Moore-Clingenpeel M, Tobias JD.

Pediatr Crit Care Med. 2017 Sep;18(9):831-837. doi: 10.1097/PCC.0000000000001226.

PMID:
28598946
3.

Remifentanil for Sedation of Children With Traumatic Brain Injury.

Hungerford JL, O'Brien N, Moore-Clingenpeel M, Sribnick EA, Sargel C, Hall M, Leonard JR, Tobias JD.

J Intensive Care Med. 2019 Jul;34(7):557-562. doi: 10.1177/0885066617704390. Epub 2017 Apr 20.

PMID:
28425334
4.

MESECTODERMAL LEIOMYOMA OF THE CILIARY BODY PRESENTING AS ANTERIOR STAPHYOMA.

Lavric A, Tsimpida M, Hungerford JL, M L Cohen V.

Retin Cases Brief Rep. 2017 Summer;11(3):266-268. doi: 10.1097/ICB.0000000000000337.

PMID:
27258538
5.

Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.

Pavlidou E, Burris C, Thaung C, Scheimberg I, Kingston J, Hungerford JL, Reddy MA, Sagoo MS.

JAMA Ophthalmol. 2015 Dec;133(12):1455-8. doi: 10.1001/jamaophthalmol.2015.2861.

PMID:
26334520
6.

Ruthenium-106 Plaque Brachytherapy in the Primary Management of Ocular Medulloepithelioma.

Poon DS, Reich E, Smith VM, Kingston J, Reddy MA, Hungerford JL, Sagoo MS.

Ophthalmology. 2015 Sep;122(9):1949-51. doi: 10.1016/j.ophtha.2015.03.002. Epub 2015 Apr 8. No abstract available.

PMID:
25863421
7.

Choroidal metastasis from follicular cell thyroid carcinoma masquerading as circumscribed choroidal haemangioma.

Papastefanou VP, Arora AK, Hungerford JL, Cohen VM.

Case Rep Oncol Med. 2014;2014:251817. doi: 10.1155/2014/251817. Epub 2014 Mar 11.

8.

Spectrum of RB1 mutations identified in 403 retinoblastoma patients.

Price EA, Price K, Kolkiewicz K, Hack S, Reddy MA, Hungerford JL, Kingston JE, Onadim Z.

J Med Genet. 2014 Mar;51(3):208-14. doi: 10.1136/jmedgenet-2013-101821. Epub 2013 Nov 13.

PMID:
24225018
9.

Prospective study of sentinel lymph node biopsy for conjunctival melanoma.

Cohen VM, Tsimpida M, Hungerford JL, Jan H, Cerio R, Moir G.

Br J Ophthalmol. 2013 Dec;97(12):1525-9. doi: 10.1136/bjophthalmol-2013-303671. Epub 2013 Sep 24.

10.

Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma.

Phillips TJ, McGuirk SP, Chahal HK, Kingston J, Robertson F, Brew S, Roebuck D, Hungerford JL, Herod J.

Paediatr Anaesth. 2013 Oct;23(10):940-5. doi: 10.1111/pan.12162. Epub 2013 May 13.

PMID:
23668238
11.

The use of strontium-90 Beta radiotherapy as adjuvant treatment for conjunctival melanoma.

Cohen VM, Papastefanou VP, Liu S, Stoker I, Hungerford JL.

J Oncol. 2013;2013:349162. doi: 10.1155/2013/349162. Epub 2013 Jan 31.

12.

The biology of micrometastases from uveal melanoma.

Borthwick NJ, Thombs J, Polak M, Gabriel FG, Hungerford JL, Damato B, Rennie IG, Jager MJ, Cree IA.

J Clin Pathol. 2011 Aug;64(8):666-71. doi: 10.1136/jcp.2010.087999. Epub 2011 May 18.

PMID:
21593344
13.

Novel mutation in PANK2 associated with retinal telangiectasis.

Sohn EH, Michaelides M, Bird AC, Roberts CJ, Moore AT, Smyth D, Brady AF, Hungerford JL.

Br J Ophthalmol. 2011 Jan;95(1):149-50. doi: 10.1136/bjo.2010.183616. Epub 2010 Oct 24. No abstract available.

PMID:
20974629
14.

Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.

Papageorgiou KI, Cohen VM, Bunce C, Kinsella M, Hungerford JL.

Br J Ophthalmol. 2011 Feb;95(2):166-70. doi: 10.1136/bjo.2009.176198. Epub 2010 Oct 1. Review.

PMID:
20889528
15.

Histopathologically proven mucinous cystadenocarcinoma metastatic to the choroid.

Henderson RH, Cohen VM, Rath PP, Luthert P, Hungerford JL.

Retin Cases Brief Rep. 2010 Spring;4(2):181-3. doi: 10.1097/ICB.0b013e31819b19db.

PMID:
25390397
16.

Transpositional Autokeratoplasty in a Patient with Unilateral Choroidal Melanoma and Contralateral Exposure Keratopathy.

Mehta H, Hungerford JL, Gartry DS, Herbert HM, Mruthyunjaya P.

Ophthalmic Surg Lasers Imaging. 2010 Mar 9:1-3. doi: 10.3928/15428877-20100215-41. [Epub ahead of print]

PMID:
20337330
17.

Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.

Chan MP, Hungerford JL, Kingston JE, Plowman PN.

Br J Ophthalmol. 2009 Jul;93(7):891-4. doi: 10.1136/bjo.2007.129981. Epub 2009 Mar 26.

PMID:
19329423
18.

Retinoblastoma: treatment and survival in Great Britain 1963 to 2002.

MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, Stiller CA, Vincent TJ, Murphy MF.

Br J Ophthalmol. 2009 Jan;93(1):38-9. doi: 10.1136/bjo.2008.139626. Epub 2008 Oct 6.

PMID:
18838414
19.

Retinoblastoma in Great Britain 1963-2002.

MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, Onadim Z, Stiller CA, Vincent TJ, Murphy MF.

Br J Ophthalmol. 2009 Jan;93(1):33-7. doi: 10.1136/bjo.2008.139618. Epub 2008 Oct 6.

PMID:
18838413
20.

The success of primary chemotherapy for group D heritable retinoblastoma.

Cohen VM, Kingston J, Hungerford JL.

Br J Ophthalmol. 2009 Jul;93(7):887-90. doi: 10.1136/bjo.2008.142679. Epub 2008 Aug 14.

PMID:
18703556
21.

Choroidal neovascularization induced by transcleral microdiathermy for localization of a juxtapapillary choroidal melanoma.

Cohen VM, Hungerford JL.

Ophthalmic Surg Lasers Imaging. 2007 Sep-Oct;38(5):410-2. doi: 10.3928/15428877-20070901-11.

PMID:
17955849
22.

Malignant transformation of iris melanocytoma to iris ring melanoma.

Sagoo MS, Mruthyunjaya P, Cree I, Luthert PJ, Hungerford JL.

Br J Ophthalmol. 2007 Nov;91(11):1571-2. No abstract available.

23.

Gastric metastases from conjunctival melanoma.

Cohen VM, Ahmadi-lari S, Hungerford JL.

Melanoma Res. 2007 Aug;17(4):255-6.

PMID:
17625457
24.

Presence and phenotype of dendritic cells in uveal melanoma.

Polak ME, Borthwick NJ, Johnson P, Hungerford JL, Higgins B, Di Palma S, Jager MJ, Cree IA.

Br J Ophthalmol. 2007 Jul;91(7):971-6. Epub 2007 Mar 8.

25.

Post-menopausal bleeding: a rare presentation of metastatic uveal melanoma.

Coutts MA, Borthwick NJ, Hungerford JL, Cree IA.

Pathol Oncol Res. 2006;12(3):184-7. Epub 2006 Sep 23.

26.

The effect of imatinib mesylate (Glivec) on human tumor-derived cells.

Knight LA, Di Nicolantonio F, Whitehouse PA, Mercer SJ, Sharma S, Glaysher S, Hungerford JL, Hurren J, Lamont A, Cree IA.

Anticancer Drugs. 2006 Jul;17(6):649-55.

PMID:
16917210
27.

Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?

Gombos DS, Cauchi PA, Hungerford JL, Addison P, Coen PG, Kingston JE.

Br J Ophthalmol. 2006 Sep;90(9):1168-72. Epub 2006 May 17.

28.

Proton beam therapy and iris neovascularisation in uveal melanoma.

Boyd SR, Gittos A, Richter M, Hungerford JL, Errington RD, Cree IA.

Eye (Lond). 2006 Jul;20(7):832-6. Epub 2005 Sep 16.

PMID:
16167079
29.

Tamoxifen-induced regression of a choroidal metastasis in a man.

Cohen VM, Moosavi R, Hungerford JL.

Arch Ophthalmol. 2005 Aug;123(8):1153-4. No abstract available.

PMID:
16087857
30.

Recruiting donors for autopsy based cancer research.

Thombs J, Borthwick NJ, Hungerford JL, Cree IA.

J Med Ethics. 2005 Jun;31(6):360-1.

31.

Globe conserving treatment of the only eye in bilateral retinoblastoma.

Lee V, Hungerford JL, Bunce C, Ahmed F, Kingston JE, Plowman PN.

Br J Ophthalmol. 2003 Nov;87(11):1374-80.

32.

Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.

Edmunds SC, Cree IA, Dí Nícolantonío F, Hungerford JL, Hurren JS, Kelsell DP.

Br J Cancer. 2003 May 6;88(9):1403-5.

33.

Current trends in the treatment of ocular melanoma by radiotherapy.

Hungerford JL.

Clin Exp Ophthalmol. 2003 Feb;31(1):8-13.

PMID:
12580888
34.

The chemosensitivity profile of retinoblastoma.

Di Nicolantonio F, Neale M, Onadim Z, Hungerford JL, Kingston JL, Cree IA.

Recent Results Cancer Res. 2003;161:73-80.

PMID:
12528800
35.

Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.

Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.

Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2845-51.

PMID:
12202501
36.

Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.

Boyd SR, Tan D, Bunce C, Gittos A, Neale MH, Hungerford JL, Charnock-Jones S, Cree IA.

Br J Ophthalmol. 2002 Apr;86(4):448-52.

37.

Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.

Boyd SR, Tan DS, de Souza L, Neale MH, Myatt NE, Alexander RA, Robb M, Hungerford JL, Cree IA.

Br J Ophthalmol. 2002 Apr;86(4):440-7.

38.

Primary orbital melanoma masquerading as vascular anomalies.

Lee V, Sandy C, Rose GE, Moseley IM, Cree I, Hungerford JL.

Eye (Lond). 2002 Jan;16(1):16-20. Review.

39.

Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age.

Gombos DS, Kelly A, Coen PG, Kingston JE, Hungerford JL.

Br J Ophthalmol. 2002 Jan;86(1):80-3.

40.

Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma.

Neale MH, Myatt NE, Khoury GG, Weaver P, Lamont A, Hungerford JL, Kurbacher CM, Hall P, Corrie PG, Cree IA.

Melanoma Res. 2001 Dec;11(6):601-9.

PMID:
11725206
41.

Differential immunoreactivity of melanocytic lesions of the conjunctiva.

Sharara NA, Alexander RA, Luthert PJ, Hungerford JL, Cree IA.

Histopathology. 2001 Oct;39(4):426-31.

PMID:
11683945
42.

Abnormalities of the transforming growth factor-beta pathway in ocular melanoma.

Myatt N, Aristodemou P, Neale MH, Foss AJ, Hungerford JL, Bhattacharya S, Cree IA.

J Pathol. 2000 Dec;192(4):511-8.

PMID:
11113869
43.

Relationship between expression of topoisomerase II isoforms and chemosensitivity in choroidal melanoma.

Satherley K, de Souza L, Neale MH, Alexander RA, Myatt N, Foss AJ, Hungerford JL, Hickson ID, Cree IA.

J Pathol. 2000 Oct;192(2):174-81.

PMID:
11004693
44.

Exposure of primary orbital implants in postenucleation retinoblastoma patients.

Lee V, Subak-Sharpe I, Hungerford JL, Davies NP, Logani S.

Ophthalmology. 2000 May;107(5):940-5; discussion 946.

PMID:
10811087
45.

Repair of late retinal detachment after successful treatment of retinoblastoma.

Madreperla SA, Hungerford JL, Cooling RJ, Sullivan P, Gregor Z.

Retina. 2000;20(1):28-32.

PMID:
10696743
46.

Delay in diagnosis of retinoblastoma: risk factors and treatment outcome.

Goddard AG, Kingston JE, Hungerford JL.

Br J Ophthalmol. 1999 Dec;83(12):1320-3.

47.
48.

Ring melanoma--a rare cause of refractory glaucoma.

Lee V, Cree IA, Hungerford JL.

Br J Ophthalmol. 1999 Feb;83(2):194-8.

49.

Predictive power of screening tests for metastasis in uveal melanoma.

Hicks C, Foss AJ, Hungerford JL.

Eye (Lond). 1998;12 ( Pt 6):945-8.

PMID:
10325992
50.

Proton beam therapy for posterior pole circumscribed choroidal haemangioma.

Lee V, Hungerford JL.

Eye (Lond). 1998;12 ( Pt 6):925-8.

PMID:
10325987

Supplemental Content

Loading ...
Support Center